Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System
Elizabeth C. Goode(University of East Anglia), Simon Rushbrook(National Health Service), Mark Hudson(The Open University), Michael A. Heneghan(King's College London), Mark Aldersley(St James's University Hospital), Kate D. Lynch(Royal Adelaide Hospital), Sun‐Gou Ji(Wellcome Sanger Institute), Carl A. Anderson(Wellcome Sanger Institute), Edit Castren(Norfolk and Norwich University Hospital), Gideon M. Hirschfield(University Health Network), Andrew Bathgate(University of Cambridge), Kelly Spiess(University of Cambridge), George Mells(Cambridge University Hospitals NHS Foundation Trust), Roger W. Chapman, Tom H. Karlsen(Oslo University Hospital), Mette Vesterhus(Deaconess Hospital), Martine Walmsley(Program Support Center), Palak Trivedi(University Hospitals Birmingham NHS Foundation Trust), Allan Clark(University of East Anglia), Graeme Alexander(Addenbrooke's Hospital), Brijesh Srivastava(University of Thessaly), William Gelson(Addenbrooke's Hospital), Richard Sandford(University of Cambridge), Douglas Thorburn(Royal Free London NHS Foundation Trust)
Cited by 106
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k